How and when tumoral clones start spreading to surrounding and distant tissues is currently 1 unclear. Here, we leveraged a model-based evolutionary framework to investigate the 2 demographic and biogeographic history of a colorectal cancer. Our analyses strongly support 3 an early monoclonal metastatic colonization, followed by a rapid population expansion at both 4 primary and secondary sites. Moreover, we infer a hematogenous metastatic spread seemingly 5 under positive selection, plus the return of some tumoral cells from the liver back to the colon 6 lymph nodes. This study illustrates how sophisticated techniques typical of organismal 7 evolution can provide a detailed picture of the complex tumoral dynamics over time and space. 8
Cancer has long been recognized as a somatic evolutionary process mainly driven by continuous 9
Darwinian natural selection, in which cells compete for space and resources 1 . With the increasing 10 availability of high-throughput genomic data, several studies have started to explore the 11 evolutionary relationships of tumor clones in order to identify the key molecular changes driving 12 cancer progression 2 , to better understand the subclonal architecture of tumors 3,4 , and to 13 determine the origins of metastases 5 . While sophisticated inferential methods have been put 14 forward that make use of sequencing data to investigate the timing and the patterns of 15 geographical dispersal of organismal lineages 6, 7 , their application in cancer research has only 16 recently started 8, 9 . 17 18
In metastatic colorectal cancer (mCRC) many aspects underlying the dissemination of cancer cells 19 to tissues beyond primary lesions have been difficult to determine. Although earlier models of 20 mCRC progression have proposed a sequential metastatic cascade, with cells from the primary 21 tumor first escaping to local lymph nodes from where they seed distant tissues 10 , conflicting 22 evidence has recently emerged, as some genomic datasets seem to favor an independent origin 23 of distant and lymph node metastases 5 . Here, to better understand the tempo and mode of 24 diversification of the tumoral cells within the human body, we sampled and analyzed whole-25 exome sequencing data from 18 different locations of a mCRC (Fig. 1A) Fig. 2 ), diverging within a short period of evolutionary 47 time (posterior median divergence time = 2.58 years) from the ancestor of the tumor sample 48 (tMRCA) (Fig. 2B) . Despite the lack of a significant overall departure from neutrality across 49 branches, evidence of positive selection (i.e., ratio of substitution rates at non-synonymous and 50 synonymous sites (dN/dS) > 1) was found for four specific branches in the phylogeny, including 51 the ancestral lineage that gave rise to all the metastatic clones, pointing out to changes 52 potentially relevant for the acquisition of metastatic capabilities ( Fig. 2A) . The most notable 53 mutation in this branch was a non-synonymous mutation in ANGPT4, an angiogenic gene known 54 to promote cancer progression in multiple cancer types 13, 14 . 55 56
Furthermore, the Bayesian skyline plot (Fig. 2C) shows that the tumor underwent a very rapid 57 demographic expansion coincident with the diversification of both primary tumor and metastatic 58 clades, before eventually becoming stationary. Interestingly, the expansion of the metastatic 59 clade seems to slightly precede the one associated with the primary tumor. The colonization history of this tumor appears to have been quite complex. A dispersal-extinction 64 biogeographic analysis placed the origin of sampled lineages around the geographical center of 65 the primary tumor (Fig. 3A) , subsequently radiating outwards in multiple directions. Additionally, 66
we inferred with high confidence that the ancestral metastatic clone experienced an early long-67 distance dispersal to the liver (Fig. 3B ), followed by a proliferation towards the nearby hepatic 68 lymph nodes before eventually spreading "back" to the colonic lymph nodes. The number of 69 implied migrations and movements was surprisingly high (Fig. 3C) . Importantly, a distance-70 dependent model was heavily favored over a distance-independent model (Fig. 3D ), suggesting 71 an overall negative correlation between geographical distance and the dispersal ability of the 72 tumoral clones at the whole patient level. 73 74
Collectively, our analyses provide a detailed picture of the evolutionary history of this tumor. 75
While we are not the first ones applying Bayesian phylogenetics for cancer dating 8,9,15 , previous 76 attempts used sample trees and absence/presence mutational profiles instead of clonal 77 phylogenies and clonal sequences, and therefore are subject to potential biases 16, 17 . Besides, the 78 evolutionary framework presented here has several advantages over previous approaches. For 79 example, it is based on Bayesian estimates obtained only after contrasting competing 80 evolutionary and demographic models under a rigorous model selection framework. Also, our 81 biogeographic approach allows for the presence of the same ancestral clone at more than one 82 location, and is able to consider the spatial distance among samples, unlike the approach of El-83
Kebir et al. 17 . On the other hand, our analyses imply a series of assumptions. In particular, it 84 presumes that the clonal genotypes were appropriately reconstructed. Indeed, clonal 85 deconvolution remains a very hard problem 18 , and we cannot rule out some degree of 86 uncertainty in the precise combination of mutations assigned to any given clone. Nevertheless, 87
we were reassured to some extent by the fact that comparable clonal genotypes were obtained 88 when using a different deconvolution approach 19 ( Supplementary Fig. 3 ). Moreover, our 89 biogeographic model assumes that the geographical distances among samples more or less 90 reflect the true "migration likelihood" of the tumoral clones. While we cannot prove that the 91 distances used are realistic in this regard, different sets of distance matrices resulted in similar 92 biogeographic solutions ( Supplementary Fig. 4 Supplementary Fig. 5 ), using a different approach 17 . 117 118
In conclusion, we believe that this study demonstrates the utility of a sound evolutionary 119 framework for exploring the spatio-temporal dynamics of cancer cell populations from multi-120 regional sequencing data. By integrating concepts from population genetics, phylogenetics and 121 biogeography, we were able to resolve the spatial architecture of this cancer, temporally connect 122 phylogenetic events at time scales compatible with clinical observations, and recover past 123 demographic changes shaping the spatial distribution of malignant clones. As more data 124 continues to accumulate, future studies could extend these type of evolutionary analyses to 125 other patients and cancer types, including polyclonal metastatic tumors 5 , in order to obtain a 126 more comprehensive and meaningful understanding of the cancer spread, which could ultimately 127 be used to predict clinical outcomes, and guide targeted treatments 23 . 128 129
Methods

130
Sample collection. A 51-year-old man was admitted to the University Hospital of Santiago de 131
Compostela (CHUS) with a one-month history of weakness and weight loss. The patient died five 132 days after admission, and the pathological assessment revealed a low-grade, moderately 133 differentiated, adenocarcinoma of the descending colon, with multiple metastatic lymph-nodes, 134 liver metastases, a metastatic focus in the right diaphragmatic peritoneum and multiple 135 intravascular micrometastases in both lungs (pT4aN2bM1c) 24 . During the warm autopsy, 136 performed by JMC, a total of 18 samples were collected, including eight from the primary tumor 137 (C1-C8), two from colonic lymph-node metastases (CL1, CL2), two from hepatic lymph-node 138 metastases (HL1, HL2), four from liver metastases (L1-L4), and two healthy samples from the 139 colon (N1, N2) (Fig. 1A) we assessed the correlation between genetic (measured via FST estimates) and geographical 171 distance, using the Mantel test function in the adegenet R package 27 ( Supplementary Fig. 1 Demographic analysis. Demographic changes in the cancer cell population were inferred from a 201
Bayesian skyline plot (BSP) analysis carried out in BEAST 2.4.7. The same prior distributions 202 described above were used, with the exception of the coalescent tree prior, which was set to 203 "Coalescent Bayesian skyline". The final skyline reconstruction was obtained using Tracer v1.6, 204 setting the number of bins to 100 and the age of the youngest tip to 0 (i.e., the time of collection 205 looking backwards 
